Emraclidine
CAS No. 2170722-84-4
Emraclidine( CVL-231 )
Catalog No. M28837 CAS No. 2170722-84-4
Emraclidine is a muscarinic M4 receptor positive allosteric modulator and can be used in neurological diseases studies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 337 | In Stock |
|
| 2MG | 179 | In Stock |
|
| 5MG | 306 | In Stock |
|
| 10MG | 493 | In Stock |
|
| 25MG | 882 | In Stock |
|
| 50MG | 1172 | In Stock |
|
| 100MG | 1553 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEmraclidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionEmraclidine is a muscarinic M4 receptor positive allosteric modulator and can be used in neurological diseases studies.
-
DescriptionEmraclidine is a muscarinic M4 receptor positive allosteric modulator and can be used in neurological diseases studies.
-
In Vitro——
-
In Vivo——
-
SynonymsCVL-231
-
PathwayCell Cycle/DNA Damage
-
TargetAChR
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2170722-84-4
-
Formula Weight390.4
-
Molecular FormulaC20H21F3N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (64.04 mM)
-
SMILESCc1cc(C)nc(C2)c1CN2C(CC(C1)CN1c1cc(C(F)(F)F)ncc1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tang Y, et al. Effect of Syringopicroside Extracted from Syringa oblata Lindl on the Biofilm Formation of Streptococcus suis. Molecules. 2021 Feb 27;26(5):1295.
molnova catalog
related products
-
Darifenacin
Darifenacin (UK-88525) is a muscarinic receptor M3 antagonist with anticonvulsant activity and can be used to study urinary incontinence and overactive bladder.
-
Tarafenacin D-tartra...
Tarafenacin D-tartrate (SVT-40776 D-tartrate) is a selective and potent muscarinic acetylcholine M3 receptor antagonist used in the study of overactive bladder and bronchial disorders.
-
bPiDDB
bPiDDB (N,N'-Dodecylbis-Picolinium Bromide) is a nicotinic receptor (nAChR) antagonist.
Cart
sales@molnova.com